β-Lactamase-IN-8
β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor. β-Lactamase-IN-8 can be used for researching antibacteria[1].
Product Specifications
CAS Number
[1929555-36-1]
UNSPSC
12352005
Target
Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/β-lactamase-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CC=C[C@]1([H])C2)B(O1)OC2=O)CSC
Molecular Formula
C10H14BNO4S
Molecular Weight
255.10
References & Citations
[1]Raja Reddy K, et al. Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability. Bioorg Med Chem. 2022;62:116722.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15368513 1 Vial
Lentiviral human TCOF1 sgRNA gene knockout kit - Lentiviral human TCOF1 sgRNA gene knockout kit (plasmid)
Ask
View Details 
361187-01 50 µL
SLC22A4 (Solute Carrier Family 22 Member 4, Ergothioneine Transporter, ET Transporter, Organic Cation/Carnitine Transporter 1, SLC22A4, ETT, OCTN1, UT2H) discontinued
Ask
View Details 361187-02 100 µL
SLC22A4 (Solute Carrier Family 22 Member 4, Ergothioneine Transporter, ET Transporter, Organic Cation/Carnitine Transporter 1, SLC22A4, ETT, OCTN1, UT2H) discontinued
Ask
View Details